While Azenta demonstrated strong financial management, margin expansion, and specific growth areas like next-gen sequencing, the company also faced challenges with core product revenue declines and specific segment weaknesses. The reaffirmation of guidance indicates confidence despite these headwinds.

Company Guidance

During the Azenta Q3 2025 earnings call, the company reaffirmed its full-year guidance for fiscal 2025, projecting organic revenue growth of 3% to 5% and an adjusted EBITDA margin expansion of 300 basis points. In Q3, Azenta achieved a 12.3% adjusted EBITDA margin, marking a year-over-year expansion of 260 basis points, supported by strong performance in next-generation sequencing, sample storage, and product services. Despite macroeconomic challenges, Azenta remains committed to long-term value creation, with $550 million in cash, no outstanding debt, and a robust M&A pipeline. The company continues to focus on operational improvements and customer engagement to drive growth, while anticipating a 1% revenue headwind due to reductions in NIH funding.

Adjusted EBITDA Margin Expansion

Adjusted EBITDA margin expanded by 260 basis points year-over-year, with a commitment to a full-year expansion of 300 basis points.

Strong Financial Position

Azenta holds $550 million in cash, with no outstanding debt and meaningful free cash flow generation.

Growth in Next-Gen Sequencing

Next-generation sequencing showed sustained double-digit volume growth, contributing to the overall revenue performance.

Positive Performance in China

Despite geopolitical headwinds, Azenta experienced 10% organic growth in China during the quarter.

Reaffirmed Guidance

Azenta reaffirmed its full-year 2025 guidance of 3% to 5% organic revenue growth and adjusted EBITDA margin expansion of 300 basis points.

Azenta (AZTA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

AZTA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 18, 2025	2025 (Q4)	0.19 / -	0.18	―	―	―
Aug 05, 2025	2025 (Q3)	0.14 / 0.19	0.16	18.75% (+0.03)
May 07, 2025	2025 (Q2)	0.07 / 0.05	0.05	0.00% (0.00)
Feb 05, 2025	2025 (Q1)	0.06 / 0.08	0.02	300.00% (+0.06)
Nov 12, 2024	2024 (Q4)	0.10 / 0.18	0.13	38.46% (+0.05)
Aug 06, 2024	2024 (Q3)	0.08 / 0.16	0.13	23.08% (+0.03)
May 08, 2024	2024 (Q2)	0.02 / 0.05	-0.06	183.33% (+0.11)
Feb 07, 2024	2024 (Q1)	-0.03 / 0.02	0.12	-83.33% (-0.10)
Nov 13, 2023	2023 (Q4)	0.02 / 0.13	0.16	-18.75% (-0.03)
Aug 08, 2023	2023 (Q3)	-0.03 / 0.13	0.12	8.33% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

AZTA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$32.41	$26.90	-17.00%
May 07, 2025	$25.42	$25.26	-0.63%
Feb 05, 2025	$51.97	$53.76	+3.44%
Nov 12, 2024	$45.99	$44.51	-3.22%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.